Literature DB >> 3519025

Effect of cyclosporine on in situ immune complex glomerulonephritis.

F Thaiss, M J Mihatsch, S Batsford, A Vogt, P Schollmeyer.   

Abstract

The influence of Cyclosporine A (CyA) on the development of renal injury in in situ immune complex glomerulonephritis (ICGN) in rats was examined. Left kidneys of male Wistar rats were perfused with cationized human IgG followed by an intravenous injection of rabbit anti-human IgG. CyA was given orally in a dosage of either 2.5, 15 or 25 mg/kg body weight per day in two daily injections. The amount of immune complexes deposited in the left kidney was not affected by CyA application as shown by isotopic studies. There were no differences between the control and CyA groups in respect to immunofluorescence, light and electron microscopy. Proteinuria was significantly inhibited with all treatment schedules, even when rats were first treated five days after inducing nephritis. These results show that CyA inhibits proteinuria without affecting glomerular cell accumulation/proliferation in in situ ICGN, and indicates that cellular activation at glomerular level might be prevented by CyA.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3519025

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  5 in total

Review 1.  Emerging indications for the use of cyclosporin in organ transplantation and autoimmunity.

Authors:  P A Keown
Journal:  Drugs       Date:  1990-09       Impact factor: 9.546

2.  The effect of cyclosporin A on the interstitial mononuclear cell infiltration and the induction of Heymann's nephritis.

Authors:  C Grönhagen-Riska; E von Willebrand; T Tikkanen; E Honkanen; A Miettinen; H Holthöfer; T Törnroth
Journal:  Clin Exp Immunol       Date:  1990-02       Impact factor: 4.330

3.  [The significance of eicosanoids in glomerular diseases].

Authors:  R A Stahl
Journal:  Klin Wochenschr       Date:  1986-09-15

4.  Chronic glucocorticoid therapy amplifies glomerular injury in rats with renal ablation.

Authors:  D L Garcia; H G Rennke; B M Brenner; S Anderson
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

Review 5.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.